9 patents
Utility
Methods of Treatment Using ICAM-Modulating Agents
6 Jul 23
This invention pertains to methods of treating cancer and lymphocyte mediated diseases using Intercellular Adhesion Molecule (ICAM)-modulating agents.
Theresa Deisher, Scot Wayne McKay
Filed: 1 Jun 21
Utility
Lymphocyte Population and Methods for Producing Same
30 Mar 23
This invention pertains to a novel population of lymphocytes, methods for producing these, and their use in the treatment of diseases.
Theresa Deisher, Scot Wayne McKay
Filed: 26 Feb 21
Utility
Immunoablative therapies
20 Sep 22
This invention pertains to pharmaceutical compositions comprising a glucocorticoid for use in the treatment of diseases by immunoablation.
Theresa Deisher
Filed: 20 Dec 18
Utility
Replacement of Cytotoxic Preconditioning Before Cellular Immunotherapy
26 May 22
Provided herein are therapeutic compositions and methods that keep cellular immunotherapies in the circulation or at the site of injection for extended periods of time without resorting to the use of cytotoxic preconditioning.
Theresa Deisher
Filed: 6 Dec 21
Utility
Replacement of cytotoxic preconditioning before cellular immunotherapy
11 Jan 22
Provided herein are novel therapeutic compositions and methods that keep cellular immunotherapies in the circulation or at the site of injection for extended periods of time without resorting to the use of cytotoxic preconditioning.
Theresa Deisher
Filed: 10 May 18
Utility
Immunoablative Therapies
4 Nov 21
This invention pertains to pharmaceutical compositions comprising a glucocorticoid for use in the treatment of diseases by immunoablation.
Theresa Deisher
Filed: 3 Oct 19
Utility
Stable Glucocorticoid Formulation
16 Sep 20
This invention relates to aqueous pharmaceutical formulations comprising a glucocorticoid.
Theresa Deisher, Adalbert Jarzyna, Iain Duncan
Filed: 27 May 20
Utility
Immunoablative Therapies
8 Apr 20
This invention pertains to pharmaceutical compositions comprising a glucocorticoid for use in the treatment of diseases by immunoablation.
Theresa Deisher
Filed: 19 Dec 18
Utility
Compositions and methods to inhibit stem cell and progenitor cell binding to lymphoid tissue and for regenerating germinal centers in lymphatic tissues
30 Sep 19
The present invention relates to compositions and methods of inhibiting stem cell binding to organs and tissues, including the blocking of stem cell binding to germinal centers present in lymph tissue.
Theresa Deisher
Filed: 6 May 18
- Prev
- 1
- Next
Patents are sorted by USPTO publication date, most recent first